@CardiologyTalk Profile picture

CardiologyTalk

@CardiologyTalk

Our goal is to bridge the educational gap confronting medical cardiologist and researchers with video interviews of principal investigators.

Similar User
Giuseppe Biondi-Zoccai photo

@gbiondizoccai

Vasvi Singh photo

@SinghVasvi

Felice Gragnano photo

@FeliceGragnano

Robert Mentz, MD photo

@robmentz

Alessandro Sticchi photo

@Sticchi_Alex

Sara Moscatelli photo

@saramoscatelli7

Teodora Donisan, MD photo

@TDonisan

Erik Rafflenbeul photo

@KardiologieHH

CardioUni Siena photo

@CardiouniSiena

HF Collaboratory photo

@hfcollaboratory

CardioInfo photo

@Cardioinfo_it

Tebaldi Matteo photo

@Tebaldi_Matteo

Marco Lombardi photo

@MarLombard1

Pasquale Paolisso photo

@P_Paolisso

Virtual Echocardiography photo

@ZGurtskaia

Michael H. Davidson, MD, @mdavidsonmd @NewAmsPharma shares groundbreaking results from the ROSE2 Trial on Obacetrapib! Discover a remarkable LDL cholesterol reduction with Obacetrapib + Ezetimibe, paving the way for aggressive LDL-C goals. 🎯👏 [video] buff.ly/3L7O24V

Tweet Image 1

🔬 Marc S. Sabatine, MD, from @BrighamWomens, pioneers MK0616, a Merck PCSK9 inhibitor. LDL cholesterol drops by 60.9% in hypercholesterolemia patients—a potential healthcare game-changer! [video]buff.ly/3sRbM6Z #CardioResearch #LDLCholesterol #Innovation 🌟

Tweet Image 1

📢 Obacetrapib & Edizumab combo ROSE2 positive trial results in reduction of LDL cholesterol. Watch Michael Davidson @mdavidsonmd @NewAmsPharma discuss the results buff.ly/3L7O24V

Tweet Image 1

Dr. Mason The study highlights the impact of mineral oil, corn oil, EPA, and DHA on phospholipid membrane oxidation rates. @BrighamWomens #Amarincorp #DeepakBhattMD #SamuelSherrattMD #PeterLibbyMD #ACC23 #WCCardio

Tweet Image 1

Icosapent Ethyl from 🥼 Professor Philippe Steg's discussion on the REDUCE-IT trial. Exciting to explore the remarkable benefits for patients with recent ACS. @APHP #PhilippeStegMD #ACC23 #WCCardio Watch and Share the Video Here: cardiologytalk.com/v/793

Tweet Image 1

@PrestonMasonPhD 🩺- How EPA can modulate platelet activation and thrombosis proteins in vascular endothelial cells during inflammation. @BrighamWomens #DeepakBhattMD #SamuelSherrattMD #PeterLibbyMD #ACC23 #WCCardio Watch and Share the Video Here: cardiologytalk.com/v/791

Tweet Image 1

Podcast - Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter Link to Audio: hubs.la/Q01bDV0H0

Tweet Image 1

Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter hubs.la/Q01bDSZ90

Tweet Image 1

Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM hubs.la/Q01b4vFV0

Tweet Image 1

Podcast - Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM Link to Audio: hubs.la/Q01b4x9g0

Tweet Image 1

Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies hubs.la/Q01b4g9p0

Tweet Image 1

Podcast - Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies Link to Audio: hubs.la/Q01b48nH0

Tweet Image 1

Podcast - Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF Link to Audio: hubs.la/Q01b4lnd0

Tweet Image 1

Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter hubs.la/Q01b40_l0

Tweet Image 1

Podcast - Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter Link to Audio: hubs.la/Q01b4lpF0

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.